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Chapter 15
Analysis of Breast Cancer Cell Invasion Using  
an Organotypic Culture System
Romana E. Ranftl and Fernando Calvo
Abstract
Metastasis is the main cause of cancer patient mortality. Local tumor invasion is a key step in metastatic 
dissemination whereby cancer cells dislodge from primary tumors, migrate through the peritumoral stroma 
and reach the circulation. This is a highly dynamic process occurring in three dimensions that involves 
interactions between tumor, stromal cells, and the extracellular matrix. Here we describe the organotypic 
culture system and its utility to study breast cancer cell invasion induced by cancer-associated fibroblasts. 
This is a three-dimensional model that reproduces the biochemical and physiological properties of real 
tissue and allows for investigating the molecular and cellular mechanisms involving tumor and its microen-
vironment, and their contribution to cancer cell invasion. This system provides a robust, accurate, and 
reproducible method for measuring cancer cell invasion and represents a valuable tool to improve the 
mechanistic understanding of the initial steps in metastasis.
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1 Introduction
Metastatic dissemination is the major clinical complication in most 
types of cancer and the cause of 90% of cancer-related deaths [1]. 
Invasion of cancer cells into the peritumoral stroma is a key step in 
metastasis [2, 3]. Thus, understanding the mechanisms regulating 
the invasive abilities of cancer cells is imperative to inform the 
development of therapeutic modalities to minimize cancer dis-
semination and improve patient survival [4]. Local cancer cell 
invasion is a multifunctional and dynamic process occurring in 
three dimensions that is actively modulated by the peritumoral 
stroma [5–7]. Cancer-associated fibroblasts (CAFs) are particu-
larly relevant as they can produce soluble factors that promote 
cancer cell invasion [8]. In addition, CAF-dependent matrix 
remodeling via focalized proteolysis activity [9] or actomyosin-
dependent force generation [10, 11] can lead to the formation of 
tracks through the extracellular matrix (ECM) that enable 
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 subsequent cancer cell invasion. Accordingly, three-dimensional 
(3D) models of cancer cell invasion that incorporate stromal com-
ponents such as fibroblasts and physiologically relevant ECMs 
recapitulate more closely the in vivo situation. These models pro-
vide a platform for investigating the complex interactions between 
tumor and its microenvironment that are more likely to lead to 
novel insights of clinical relevance.
Here, we describe a 3D organotypic invasion assay adapted for 
the robust and accurate assessment of breast cancer cell invasion 
induced by CAFs [11–13]. This approach was originally developed 
as a 3D coculture model by Fusenig and colleagues [14], and fur-
ther developed by other groups to study squamous cell carcinoma 
invasion [10, 15]. Briefly, CAFs are embedded in a dense gel com-
posed of fibrillar collagen I and basement membrane matrix 
(termed Matrigel®, Cultrex®, or Engelbroth-Holm-Swarm matrix), 
which contains laminins, collagen IV, proteoglycans, and a broad 
spectrum of growth factors (see Fig. 1). A thin layer of gel is used 
to cover the breast cancer cells seeded on the surface of the CAF- 
containing gel to mimic the physiological condition of breast tis-
sue. Gels are subsequently laid on a grid and maintained partially 
immersed in cell medium. Organotypic gels are then fixed and pro-
cessed by standard histopathological procedures followed by quan-
titative and qualitative analysis of breast cancer cell invasion using 
standard image processing and analysis software.
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Fig. 1 Schematic representation of the workflow of an organotypic invasion assay. Step 1: Embed fibroblasts 
in gel and seed in 24-well dish. Step 2: Cancer cells are seeded in a single-cell suspension on top of the gel. 
Step 3: Once the cells have adhered, remove the medium and lift the remodeled gel onto gel-coated nylon filter 
on a metal bridge. Coat the cancer cells with a thin layer of gel. Step 4: Feed with complete medium up to the 
nylon filter. Incubate at 37 °C, 5% CO2 for 5 days to allow for cancer cell invasion. Step 5: Terminate assay by 
fixing organotypic gels. Process gels for H&E staining
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2 Materials
 1. Cancer-associated fibroblasts (CAFs):
 (a) For the mouse model: CAFs from breast carcinomas from 
the FVB/n MMTV-PyMT murine model [11, 16].
 (b) For the human model: CAFs from a resection of a human 
breast carcinoma.
 2. Normal fibroblasts (NFs):
 (a) For the mouse model: NFs from mammary glands of 
FVB/n wild-type siblings [11, 16].
 (b) For the human model: NFs from a resection of a reduction 
mammoplasty.
 3. Breast cancer cells:
 (a) For the mouse model: 410.4 or 4T1 cells (ATTC®-
CRL-2539™) (see Note 1).
 (b) For the human model: MDA-MB-231 (ATCC®-HTB-26) 
(see Note 2).
 4. Fibroblast culture medium: 10% fetal bovine serum (FBS), 1× 
GlutaMax™ (Gibco®) and 1× insulin–transferrin–selenium 
(ITS, Gibco®) in Dulbecco’s modified Eagle’s medium 
(DMEM). Store at 4 °C. Warm up before use.
 5. Cancer cell culture medium: 10% FBS and 1× GlutaMax™ in 
DMEM (see Note 3). Store at 4 °C. Warm up before use.
 6. Sterile phosphate buffered saline (PBS): 3.2 mM Na2HPO4, 
0.5 mM KH2PO4, 1.3 mM KCl, 135 mM NaCl, pH 7.4. Warm 
up before use.
 7. Sterile 0.05% trypsin–0.02% EDTA. Store at 4 °C. Warm up 
before use.
 8. If a Killing Assay is performed: selective compounds such as 
puromycin (puromycin dihydrochloride from Streptomyces 
alboniger, Sigma) (see Note 4).
 1. 5× DMEM: 5% αDMEM powder (Gibco®), 2% NaHCO3 
(0.24 M NaHCO3), 0.1 M Hepes pH 7.5. Store at 4 °C (see 
Note 5).
 2. Fibroblast culture medium.
 3. FBS.
 4. Rat-tail collagen type I, high concentration (BD Biosciences). 
Store at 4 °C (see Note 6).
 5. Matrigel® (BD Biosciences). Store at −80 °C in 1 mL aliquots 
(see Note 7).
2.1 Tissue Culture
2.2 Gel Preparation
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 1. Nylon NET filters 120 μm (Merck Millipore).
 2. Sterile stainless steel metal bridges with a grid size of 2–3 mm. 
Approximate dimensions: 21 × 21 × 5 mm (Fig. 2a).
 3. Sterile forceps and spatula (Fig. 2b).
 4. Sterile PBS.
 5. Filter fixing solution: 4% paraformaldehyde (PFA) and 0.25% 
glutaraldehyde in PBS.
 1. Gel fixing solution: 4% PFA and 1% glutaraldehyde in PBS.
 2. Scalpel and forceps (Fig. 2b).
2.3 Gel Manipulation
2.4 Post Processing 
and Analysis
Fig. 2 Gel preparation and processing steps. (a) Metal bridges with approximate dimensions indicated. 
(b) Useful tools for handling the organotypic cultures, nylon filters and metal bridges. (c) Cell-free or fibroblast- 
containing gels are plated in a 24-well plate on ice. (d) The ability of fibroblasts to contract the collagen:Matrigel 
gel (a measure of their matrix remodeling capacity) can be documented prior to further processing. Images 
show duplicate samples of organotypic cultures free of cells and with different human CAFs that have low (“l”), 
medium (“m”), and high (“h”) contractility, as indicated. (e, f) Nylon filters are soaked in gel (e) and then sepa-
rated in a culture dish for setting and fixing (f). (g–k) Setting up the organotypic gel on the metal bridges. 
Sterile bridges are placed in a 6-well plate (g) and covered by a nylon filter (h). The organotypic cultures are 
lifted from the 24-well plate and placed over the filter:bridge using a spatula (i); a thin gel layer is added on 
the top to cover the cancer cell monolayer (j); and complete medium is added to the 6-well dish until soaking 
the nylon filter underneath the organotypic gel (k)
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 3. 70% ethanol.
 4. Standard materials for paraffin embedding and hematoxylin 
and eosin (H&E) staining.
 5. Bright field microscope with 20× (or 10×) objective and 
camera.
 6. Image analysis software (Image J—http://imagej.nih.gov/
ij—or similar).
3 Methods
This protocol is an adapted version of a previously described 
method for SCC12 carcinoma cells [10] (see Fig. 1 for a schematic 
representation). We have optimized the organotypic invasion assay 
for murine and human breast cancer cells (410.4/4T1 and 
MDA-MB-231) in combination with murine or human fibroblasts, 
respectively (see Note 8). On a general basis, cancer cells are not 
invasive in this setting and rely on CAF activities to invade. It is 
recommended to test the behavior of alternative cancer cell types 
in the assay by plating them on top of a fibroblast-free gel matrix. 
Heterogeneity is also observed in CAFs in terms of their ability to 
contract and remodel gel matrices. The amount of fibroblasts and 
cancer cells to be used, as well as the length of the protocol, need 
to be optimized if alternative models are used (see Note 9).
All components of the gel mix must be kept on ice. Here we 
describe the protocol for 1 mL gel mix containing fibroblasts or 
without fibroblasts. This is the volume required for one sample in 
one well of a 24-well plate. The total volume of gel mix needs to 
be scaled up according to sample size. Generally, it is recommended 
to prepare gel in excess to avoid pipetting errors due to the viscous 
nature of the components.
 1. Prechill all components for the gel preparation on ice.
 2. Mix 100 μL FBS, 80 μL 5× DMEM, and 120 μL of fibroblast 
culture medium.
 3. Add 200 μL of Matrigel® and 400 μL of collagen I (see Notes 
10 and 11). Keep the mixture on ice (see Note 12).
 4. Trypsinize fibroblasts of interest (NFs/CAFs) from a mono-
layer to a single cell suspension. Count the cells, centrifuge 
(400 × g for 5 min), and resuspend the pellet at a concentra-
tion of 107 cells/mL in fibroblast culture medium (see Notes 
13 and 14).
 5. Avoiding bubble formation, add 100 μL of the cell suspension 
to the gel mix. If a gel without fibroblasts is required, add 
100 μL of fibroblast culture medium instead of cell suspension 
(see Note 15).
3.1 Gel Preparation
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 6. Add 900 μL of the mixture in a 24 well-plate well (Fig. 2c) (see 
Note 16).
 7. Place the plate at 37 °C and 5% CO2 for 1 h.
 8. When the gel is set, add 1 mL of appropriate medium on top 
and incubate overnight at 37 °C and 5% CO2 (see Note 17).
Depending on the number and matrix-remodeling ability of the 
fibroblasts, some of the gels may have already contracted at this 
point. The plate can be scanned to document this, as gel contrac-
tion can serve as an additional read-out of CAF function (Fig. 2d).
 1. Trypsinize a monolayer of breast carcinoma cells (4T1, 410.4 
or MBA-MD-231), count the cells and prepare a single cell 
suspension at 5 × 106 cells/mL in cancer cell culture medium.
 2. Aspirate the medium carefully from the 24-well plate contain-
ing the gels.
 3. Apply 100 μL of the cancer cell suspension on the top of each 
of the gels (see Notes 18 and 19).
 4. Incubate at 37 °C and 5% CO2. Leave the cells to adhere to the 
matrix for 6–8 h.
Given the softness of the gels, direct contact with the metal can 
damage the gels. Before placing the gels on the bridges, nylon fil-
ters have to be prepared and placed in-between the gels and the 
metal grid.
 1. Prepare the adequate number of nylon filters (1 per organo-
typic condition) with a sterile forceps on top of each other in a 
culture dish.
 2. Prepare 1 mL of gel without fibroblasts according to the recipe 
described in Subheading 3.1.
 3. Coat the nylon filters using 1 mL of cell-free gel (Fig. 2e).
 4. Separate the coated filters in the culture dish (Fig. 2f).
 5. Incubate the coated nylon filters at 37 °C for 1 h.
 6. Fix the coated nylon, using filter fixing solution for at least 2 h 
at room temperature (RT) or overnight at 4 °C.
The gels are placed on the metal bridges and medium is fed from 
underneath to impose a direction of invasion. The breast cancer 
cell layer is covered with a thin layer of gel for improved simulation 
of in vivo conditions (see Note 20).
 1. Wash the gel-coated nylon filters with sterile PBS for 10 min 
(×3) to remove all traces of fixing solution.
 2. Add cancer cell culture medium to the filters and incubate for 
30 min at 37 °C.
3.2 Breast Cancer 
Cell Preparation
3.3 Coating of Nylon 
Filters
3.4 Lifting the Gel 
and Covering 
the Cancer Cells
Romana E. Ranftl and Fernando Calvo
205
 3. Place the sterile metal grid bridges in a 6-well plate with sterile 
forceps (Fig. 2g).
 4. Add a coated, washed and medium-adapted nylon filter on top 
of each metal bridge with sterile forceps (Fig. 2h).
 5. Prepare an appropriate amount of cell-free gel according to the 
recipe in Subheading 3.1 and keep the mixture on ice (100 μL 
per organotypic gel).
 6. Remove the medium on the top of the gels carefully in order 
not to disturb the organotypic cultures.
 7. Lift the gels with a sterile spatula from the 24-well and place it 
on a coated filter on top of a metal bridge. The cancer cell layer 
must be facing up (Fig. 2i, j).
 8. Add medium under the bridge until it is in contact with the 
nylon filter. Avoid air bubbles between the interphase 
medium/nylon filter (Fig. 2k).
 9. Add 100 μL of the cell-free gel mixture on top of the lifted gels 
and spread over the surface.
 10. Incubate the culture for 5 days (37 °C, 5% CO2) and change 
the medium daily (see Note 21).
 1. After culturing for 5 days (see Note 9), remove the medium 
from the plate and wash with PBS or transfer the organotypic 
cultures to a new 6-well plate by lifting the filter and gel. Turn 
the gel upside-down for fixing (cancer cell layer on the bot-
tom, Fig. 1) (see Note 22).
 2. Fix the gels in 2 mL of gel fixing solution at 4 °C overnight.
 3. Next day, wash the gels with PBS (2 mL) for 10 min (×3).
 4. Using the forceps and the scalpel cut the gel in two halves and 
store one of them in 70% ethanol at 4 °C (see Note 23).
 5. Embed the other half of the gel in paraffin blocks and perform 
standard H&E staining on sections (see Notes 24 and 25).
 1. Take 5–7 pictures per gel using a bright field microscope 
(20×/10× magnification) (see Note 26 and Fig. 3a–e).
 2. Measure the area of noninvasive cancer cells and the total area 
of cancer cells (noninvasive and invasive) using Image J or a 
similar software (Fig. 3f).
 3. The Invasion Index is calculated by dividing the invading area 
(total area − invading area) by the total area (see Note 27).
CAFs have been shown to form tracks in the ECM, which has been 
associated with increased invasiveness of cancer cells [10]. However, 
CAFs can also produce soluble factors that can promote cancer cell 
invasion [8]. The basic organotypic invasion assay described above 
does not allow discriminating between these two abilities.
3.5 Gel Fixing 
and Processing
3.6 Data Analysis
3.7 Killing Assay
Organotypic Invasion Assay
206
Fig. 3 Analysis of cancer cell invasion using carcinoma cells in an organotypic invasion assay. (a) Representative 
image of H&E staining of an organotypic invasion assay of 4T1 cells cultured in the presence of CAFs. The 
different parts of the organotypic gel are indicated. Right panel is a zoom up region that shows both collective 
and single cell invasion of 4T1 cells. Fibroblasts and ECM fibers are also observed. (b) Representative images 
of H&E staining of organotypic invasion assays of 4T1 murine breast cancer cells cultured in the absence and 
presence of either murine normal fibroblasts (NFs) or PyMT-CAFs. Invasion indexes of 4T1 cells for each
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In order to specifically study the capacity of CAFs to form 
tracks in the gel that allow subsequent cancer cell invasion, as 
well as the potential of cancer cells to invade a gel previously 
remodeled by CAFs, a variation of the basic organotypic culture 
assay can be performed: the “killing” assay. Fibroblasts are seeded 
as described earlier and are allowed to remodel the gel matrix for 
5 days before they are removed. When cancer cells are seeded on 
top of the gel, they will invade into the tracks formed by the 
fibroblasts (Fig. 3c). This modified version also allows for dis-
criminating the selective effect of chemical compounds on fibro-
blasts/cancer cells as both compartments are never cultured 
together.
 1. Follow the protocol as described in Subheading 3.1 (steps 
1–8). Once the gel is set, add 1 mL of fibroblast culture 
medium on top.
 2. Incubate at 37 °C, 5% CO2 for 5 days. Change the medium 
daily (see Notes 17 and 28).
 3. Fibroblast removal (“killing” step): Remove the medium from 
the gels and add 1 mL of fibroblast culture medium containing 
an appropriate selection compound (e.g., 10 μg/mL puromy-
cin) (see Note 29).
 4. Incubate at 37 °C, 5% CO2 for 48 h.
 5. Wash the gels for 1 h in fibroblast culture medium (×3). 
Incubate at 37 °C, 5% CO2 overnight in fibroblast culture 
medium to remove all traces of selection compound (see 
Note 30).
 6. Continue with the procedure as described in Subheadings 
3.2–3.6.
Fig. 3 (continued) experimental setup are also indicated. Scale bar, 50 μm. (c) Representative images of H&E 
staining of “killing” organotypic invasion assays of 4T1 murine breast cancer cells cultured in gels previously 
remodeled by murine normal fibroblasts, PyMT-CAFs or mock-remodeled (no fibroblasts). Invasion indexes of 
4T1 cells for each experimental set-up are also indicated. Scale bar, 50 μm. (d) Representative images of H&E 
staining of organotypic invasion assays of MDA-MB-231 human breast cancer cells cultured in the absence and 
presence of human breast cancer CAFs. The invasion index is indicated. Scale bar, 50 μm. (e) Representative 
images of H&E staining of organotypic invasion assays of 410.4 murine breast cancer cells with murine NFs and 
CAFs. Note that 410.4 cells present a “collective” mode of invasion. Scale bar, 50 μm. (f) Exemplars for image 
analysis of a representative image of H&E staining of an organotypic invasion assay of 4T1 cells cultured in the 
presence of CAFs (shown in panel a). First, the non-invaded area (red) and the total area (blue) are measured 
using Image J (http://imagej.nih.gov/ij/). The invading area is then calculated by subtracting the non-invading 
area from the total area. The invasion index is the ratio of invaded area vs. total area. Invasion index and areas 
are also indicated
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4 Notes
 1. 4T1 cells are a metastatic subpopulation of the original 410.4 
murine breast cancer cell line [17].
 2. For perturbation studies (i.e., RNAi), NFs/CAFs or cancer 
cells need to be modified before starting the protocol.
 3. ATCC and other studies may suggest different media for cul-
turing the breast cancer cell lines. However, we recommend 
using DMEM as the organotypic gels are based on it and it 
does not affect cell behavior or viability.
 4. For puromycin, make aliquots of 10 mg/mL and store at 
−20 °C.
 5. Preparation of 5× αDMEM (250 mL): dissolve 12.5 g DMEM 
powder (Gibco®) and 5 g NaHCO3 in 50 mL of sterile MilliQ 
water. Add 25 mL of sterile 1 M Hepes pH 7.5 and sterile 
MilliQ water up to 250 mL. Mix and filter the solution using 
a 0.2 mm filter in sterile conditions. Aliquot in 50 mL and 
10 mL aliquots and store at −20 °C. Thaw fresh aliquots for 
gel preparation and do not store them longer than 30 days at 
4 °C.
 6. Rat tail collagen type I, high concentration is supplied as a 
liquid in 0.02 N acetic acid with a concentration range of 
8–11 mg/mL. Note the actual concentration of each particu-
lar batch when calculating the volumes to be used during gel 
preparation (see Note 10).
 7. Matrigel® is a viscous substance at 4 °C that solidifies at 
RT. Store Matrigel® in sterile 1 mL aliquots at −80 °C and 
thaw the amount required for an experiment the night before 
at 4 °C. Note the actual concentration of each particular batch, 
as it will be required to calculate the volumes for gel prepara-
tion (see Note 10). As an alternative to Matrigel® we have 
successfully used Engelbroth-Holm-Swarm matrix from 
Sigma-Aldrich in our organotypics.
 8. We have used both murine and human CAFs in this assay. In 
our experience, murine CAFs require higher cell numbers 
than human CAFs, as the latter tend to be larger in size and 
have higher ECM remodeling abilities (see Note 13). For 
comparative studies, make sure an equal amount of NFs/
CAFs are used.
 9. To optimize the approach, it is recommended to empirically 
determine the effect of two variables: (1) the amount of NFs/
CAFs to be embedded on the gel matrix; and (2) the length of 
the protocol (i.e., how long the fibroblasts are allowed to 
remodel the gels and/or the cancer cells are allowed to invade).
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 10. The final concentrations of collagen and Matrigel® in the gel 
are set to 4 mg/mL and 2 mg/mL, respectively. The recipe 
was optimized to have almost physiological concentrations of 
collagen I and Matrigel®. In order to prepare reproducible gel 
solutions the volumes of the components have to be adapted 
accordingly, depending on the stock concentrations of 
Matrigel® and collagen I (see Notes 6 and 7). For this proto-
col we base our volume calculations on stock concentrations 
of 10 mg/mL for both collagen I and Matrigel®. The volume 
of 5× DMEM can be adapted if larger volumes of the acidic 
collagen are added to retain optimal buffering.
 11. Matrigel® and collagen I are very viscous and need to be pipet-
ted with care. Avoid bubble formation (as bubbles can be det-
rimental to the quality of the gel) and retention of gel in the 
tips (as they may affect the final concentration).
 12. Avoid leaving the gel mixture on ice for long periods of time 
as it may affect its properties.
 13. For human NFs/CAFs, resuspend the pellet to a concentra-
tion of 2.5 × 106 (see Note 8).
 14. To reduce the activating effect of FBS in fibroblasts, NFs/
CAFs can be cultured for 5–7 days in fibroblast culture 
medium supplemented with 0.5% FBS (instead of 10% FBS) 
prior to the use in the organotypic invasion assay.
 15. Cell-free gel will also be used for the nylon filter coating pro-
cedure (Subheading 3.3) and for covering the cancer cell layer 
on the top of the organotypic gel (Subheading 3.3).
 16. Do not plate the total volume of the mix in order to avoid 
pipetting errors as the gel is very viscous and sticks to pipette 
tips. Gels can set at RT; these gels will not have the exact same 
properties as the ones set at 37 °C. We recommend keeping 
the 24-well plate on ice while adding the gel, especially when 
a larger number of samples are handled. This will allow the gel 
in all wells to set at the same time.
 17. At this step, appropriate growth factors, cytokines or drugs 
can be added to the medium. Cell medium will buffer some of 
the acidity of the gels and may turn orange. For optimal 
results, replace with fresh medium after 2–3 h.
 18. Seeding 100 μL of cell suspension on the top of highly con-
tracted gels can be problematic. If needed, in these particular 
cases the empty space in the well can be covered up with fresh 
cell-free gel; this will allow cancer cells to be seeded on larger 
volumes (1 mL of 5 × 105 cell/mL suspension). However, the 
new gel only attaches loosely to the original gel and can some-
times rip off during the lifting process.
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 19. If gels have not contracted at all, cancer cells can also be 
applied in a volume of 1 mL per well (at 5 × 105 cell/mL).
 20. Alternatively, depending on the type of carcinoma cells used in 
the assay, the cells can also be grown in an air–cells–liquid 
interface. The cells are prepared and added on top of the 
fibroblast- containing organotypic culture as described in 
 Subheading 3.2. However, the cells will not be covered with a 
layer of gel.
 21. At this step, appropriate growth factors, cytokines or drugs 
can be added to the medium, bearing in mind that they will 
affect both compartments (i.e., fibroblasts and cancer cells). 
The gels will become flatter during the incubation on the 
metal bridges.
 22. Alternatively, gels can be snap-frozen for immunofluorescence 
analysis. Gels are placed in a plastic cuvette, covered by OCT 
buffer (Tissue-Tek) and immersed in liquid nitrogen. Store at 
−80 °C until further processing (see Note 25).
 23. Keep the second half as backup until good H&E staining is 
obtained or use it to perform additional analysis (see Notes 
22, 24 and 25).
 24. To allow for invasion analysis, gels must be embedded in par-
affin in the correct orientation. Tissue sections need to be 
obtained from the cut side of the organotypic gel and not on 
the top or bottom sides. Sectioning the gel within the paraffin 
block can be challenging as the noninvasive cell layer can easily 
come off during processing. We recommend very slow trim-
ming of the paraffin block at the first 500 μm to level the gel. 
Generate two to three cuts (50 μm apart) per organotypic gel 
per slide for analysis.
 25. As an alternative to H&E staining, gels can also be processed 
for immunohistochemistry or immunofluorescence detection 
of specific cancer cell or CAF markers according to standard 
protocols (see Note 22). This will ascertain the cell identity of 
the invading cells. Alternatively, fluorescence-labeled cells can 
be used in the organotypic invasion assay to allow for detec-
tion without staining procedures.
 26. Fibroblasts tend to concentrate on the borders of the gels, 
leading to artefacts on cancer cell invasion in those areas. 
Pictures need to be taken in the central part of the gel.
 27. Other analysis can also be performed. For example, Alternative 
Invasive Index (invading area/non-invading area), number of 
invading objects, area of invading cells (without measuring gel 
areas), etc.
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 28. NFs/CAFs can be allowed to remodel the gel up to 10 days 
before the cancer cells are seeded on top. The length of this 
step has to be determined empirically if other models are used.
 29. The choice of selection depends on the resistance genes 
expressed by the cells (e.g., selection-based stable RNAi/over-
expression systems previously inserted). We recommend deter-
mining the optimal final concentration beforehand.
 30. Thorough washing with PBS and medium is important; oth-
erwise cancer cells added subsequently may be affected. If this 
becomes problematic, we recommend generating stable can-
cer cells resistant to the selective compound.
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